Yu-Hang He , Hong Xiang , Zi-Jie Long , Ze-Xin Jin , Jin-Feng Hu , Yi-Cheng Mao , Juan Xiong
{"title":"Structurally diverse sesquiterpenes with anti-leukemia activity from the rare medicinal plant Liriodendron chinense","authors":"Yu-Hang He , Hong Xiang , Zi-Jie Long , Ze-Xin Jin , Jin-Feng Hu , Yi-Cheng Mao , Juan Xiong","doi":"10.1016/j.bioorg.2025.108341","DOIUrl":null,"url":null,"abstract":"<div><div>A further phytochemical investigation on the branches and leaves of <em>Liriodendron chinense</em>, a rare medicinal and ornamental plant endemic to China, yielded thirty-four sesquiterpenes with diverse skeletons. The isolated compounds comprise 12 new naturally occurring sesquiterpenoids (<strong>1</strong>−<strong>12</strong>) and 22 known analogues (<strong>13</strong>–<strong>34</strong>). The new structures were elucidated by spectroscopic data analyses, and their absolute configurations (except for <strong>10</strong>) were determined by electronic circular dichroism spectra, quantum-chemical calculations, and X-ray crystallography. Among them, liriochinolide A (<strong>1</strong>) is a rare chlorine-substituted germacrane-type sesquiterpenoid from the terrestrial plants. Bioassay evaluations revealed that most of the isolates exhibited remarkable cytotoxicity against three human leukemia cell lines (MV-4-11, HL-60 and Raji), with IC<sub>50</sub> values ranging from 2.27 to 9.69 μM. Further exploration of anti-leukemia mechanism demonstrated that the bioactive compounds <strong>5</strong>, <strong>8</strong>, and <strong>18</strong> significantly induced the cell apoptosis, which was associated with down-regulation of the anti-apoptotic proteins BCL-2 and MCL-1.</div></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"158 ","pages":"Article 108341"},"PeriodicalIF":4.5000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0045206825002214","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
A further phytochemical investigation on the branches and leaves of Liriodendron chinense, a rare medicinal and ornamental plant endemic to China, yielded thirty-four sesquiterpenes with diverse skeletons. The isolated compounds comprise 12 new naturally occurring sesquiterpenoids (1−12) and 22 known analogues (13–34). The new structures were elucidated by spectroscopic data analyses, and their absolute configurations (except for 10) were determined by electronic circular dichroism spectra, quantum-chemical calculations, and X-ray crystallography. Among them, liriochinolide A (1) is a rare chlorine-substituted germacrane-type sesquiterpenoid from the terrestrial plants. Bioassay evaluations revealed that most of the isolates exhibited remarkable cytotoxicity against three human leukemia cell lines (MV-4-11, HL-60 and Raji), with IC50 values ranging from 2.27 to 9.69 μM. Further exploration of anti-leukemia mechanism demonstrated that the bioactive compounds 5, 8, and 18 significantly induced the cell apoptosis, which was associated with down-regulation of the anti-apoptotic proteins BCL-2 and MCL-1.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.